hit tracker
Sunday, October 2, 2022
HomeLatest NewsThe incidence of people over 60 and hospitalizations decreased for the first...

The incidence of people over 60 and hospitalizations decreased for the first time since the beginning of June

Date: October 2, 2022 Time: 19:30:45

The number of people hospitalized with coronavirus in Spain has decreased since last Friday to 11,713, the first drop since June 10. However, bed occupancy remains high, at the level of February this year, completely hungover from the sixth wave of infections. In addition, the saturation of intensive care units is 5.88%, with a total of 513 patients in intensive care units.

How is the epidemic developing and how do we feel about the 3rd wave?

Dynamics of reported cases and deaths, number of hospitalized and admitted to the intensive care unit each day, change last 7 days and comparison with the peak of the 3rd wave of the pandemic. From April 1, 2022, the infection monitoring system has changed.

Source: Ministry of Health.

This surge in occupancy comes after a new spike in cases that began in mid-May and appears to be starting to subside. Since last Tuesday, health authorities have identified 57,635 new infections. A week ago, the number of new infections was 83,613, and the previous Friday, communities reported 84,146. A total of 13,090,476 people have been infected since the start of the pandemic.

The 14-day incidence among people over 60 is 1,158.54 cases per 100,000 inhabitants, a decrease of more than 96 points compared to this Tuesday, marking the first decrease in this rate since June 10. The 14-day case has risen since June 10, when it hit a low of 578 cases, and stalled at 1255 last Tuesday, just 30 points higher than the previous day.

An increase in infections is also noted in mortality. Since Tuesday, the Ministry of Health has reported 400 coronavirus deaths, with 471 a week ago and 205 the previous Friday. In total, 109,348 people have died from this disease since the beginning of the pandemic.

Pharmaceutical companies race for vaccine leadership

Pharmaceutical companies like Moderna and Pfizer are in the middle of a race to master the next round of COVID-19 vaccines: omicron immunity before winter hits. Moderna countered Pfizer’s dominance. On June 8, the company said its new formula provides a “stronger immune response” to the variant that is responsible for the cases in late 2021. The company’s CEO Stéphane Bansel believes this is “the second case”. a test for the superiority of our bivalent vaccine”, that is, that it works against the original version of SARS-CoV-2 and on omicron.

According to its own preliminary data, “revaccination with a bivalent vaccine is our main candidate for the fall of 2022.” Why mention autumn? The European Center for Disease Control (ECDC) believes that a new wave of COVID-19 is expected this season. “Countries should plan to introduce additional doses to vulnerable populations in early autumn,” he said. And “maybe combine them with the flu campaign,” he elaborated.

Source: www.eldiario.es

*The article has been translated based on the content of www.eldiario.es. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!


Most Popular

Recent Comments

%d bloggers like this: